Satellite title |
Satellite organizer |
30/80/60 targets on community-led responses to HIV |
UNAIDS |
8th workshop on children and adolescents with perinatal HIV exposure |
IAS – the International AIDS Society/CIPHER, WHO, PATA, UNICEF, MassGeneral Hospital for Children, PHACS |
A new global Roadmap for combination HIV prevention. Intensified actions towards achieving UNAIDS 2025 targets. |
Global HIV Prevention Coalition / UNAIDS |
Accelerating investigation of novel therapeutics in pregnancy: from theory to action |
The World Health Organization (WHO); Unitaid; The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network |
Accessing long-acting HIV prevention and treatment innovations: Landscape, service delivery, and pathways to affordability |
IAS – the International AIDS Society – in collaboration with the Medicines Patent Pool |
Achieving an AIDS-free future: African leaders championing sexuality education and challenging misinformation |
Frontline AIDS, UNESCO ESA Region, Global Affairs Canada |
Achieving health equity for 2SLGBTQI+ communities: Lessons learned from the HIV response in Canada |
Public Health Agency of Canada, in collaboration with Women and Gender Equality Canada |
Addressing context in implementation research to inform global HIV service delivery priorities |
Washington University in St. Louis and John Hopkins University |
Africa HIV cure research: Strengthening industry-community engagement in clinical research |
IAS – the International AIDS Society |
Anti-racism and decolonizing the AIDS response: Moving from rhetoric to reformation |
UNAIDS, WHO, Frontline AIDS and ARASA |
Behavioral economics and conditional incentives to strengthen HIV treatment and prevention: Actioning the science |
U.S. National Institutes of Health’s National Institute of Mental Health, Division of AIDS Research & Fogarty International Center |
Beyond theory: People, providers and policymakers share practical perspectives on delivering responsive, person-centered HIV primary healthcare |
JSI, PATH |
Bringing the future forward: Accelerating progress toward HIV cure cell and gene therapies for all |
HIV Cure Africa Acceleration Partnership (HCAAP) |
Catching up on the third 95 target for children and adolescents living with HIV |
Pact |
Cervical Cancer Screening and HIV Integration: Country Experiences with HPV testing in the SUCCESS Project |
Jhpiego, Expertise France, UICC |
Communities leading the way: The importance of key population community-led responses in HIV 2022 |
MPact: Global Action for Gay Health & Rights, Global Network of Sex Worker Projects, International Network of People who Use Drugs |
Community-based participatory research: Good science for appropriate response |
ANRS | Maladies Infectieuses Emergentes |
Comprehensive Advanced HIV Disease Programming |
Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) |
Demand, delivery and data for decision-making: How market preparation for the Dual Prevention Pill is reimagining prevention programs for a future with MPTs |
AVAC, CHAI, Population Council, Expanding Effective Contraceptive Options (EECO) Project, Catalyst Global, NYU Grossman School of Medicine |
Differentiated service delivery for Advanced HIV Disease: a health systems strengthening approach to improving the coverage and quality of AHD services |
ICAP at Columbia University |
Differentiated Service Delivery for People Who Inject Drugs (PWID) in Africa: Priorities and Lessons Learned |
ICAP at Columbia University, FHI 360’s Meeting Targets and Maintaining Epidemic Control (EpiC) project, the South-to-South HIV prevention learning network, and the International Network of People who Use Drugs |
Differentiated Testing Services: Optimizing program design to enhance testing and linkage |
ICAP at Columbia University and the Clinton Health Access Initiative (CHAI) |
Doing the right thing: Mitigating HIV-related stigma in clinical settings |
IAS – the International AIDS Society / Getting to the Heart of Stigma and Me and My Healthcare Provider |
Don’t call me resilient : HIV, resiliency, connection and diversity |
The Positive Leadership Development Institute (PLDI) | L’Institut de développement du leadership positif (IDLP) |
Drugs, HIV and community involvement: a 360 degree vision on how to approach harm reduction practices and policies |
Coalition PLUS |
Empowering communities in global and national policy and implementation: lessons from the Unitaid Optimal Project |
Clinton Health Access Initiative, Inc. (CHAI), Unitaid, and AfroCAB |
Ending HIV stigma: we know what works, we need to do more of it |
GNP+, ICW, Y+ Global |
Evidence for PrEP Implementation in Latin America: ImPrEP Project Results |
Evandro Chagas National Institute of Infectious Diseases / Oswaldo Cruz Foundation (Fiocruz) |
Evidence to action: Focus on emerging HIV research leaders in Canada |
Canadian Institutes of Health Research (CIHR) |
Expanding access to HIV self-testing |
MedAccess |
Expanding access to PrEP through differentiated service delivery: Lessons from COVID-19 adaptations |
IAS – the International AIDS Society and the World Health Organization (WHO) |
Expanding COVID-19 vaccination coverage among key populations and people living with HIV |
EpiC and OutRight Action International |
Expanding the strategies of testing and telemonitoring at primary health care to contribute to the fight against COVID-19 in low- and middle-income countries |
Federal University of Bahia; State University of Bahia; Evandro Chagas National Institute of Infectious Diseases/Oswaldo Cruz Foundation (Fiocruz) |
Experimental medicine trials in Africa: ethical considerations and community engagement |
IAS – the International AIDS Society/Global HIV Vaccine Enterprise with AVAC – AIDS Vaccine Advocacy Coalition |
Fight For What Counts: Maximizing health equity, gender equality and human rights in the HIV response |
The Global Fund to Fight AIDS, TB and Malaria |
Fun and friendship: An innovative health and psychosocial intervention for young people living with HIV |
ASHA Foundation, Bangalore, and SeriousFun Children’s Network |
Getting person-centred care right: Good practice models of integrating HIV and other health needs |
IAS – the International AIDS Society |
Harm Reduction on the Front-Lines in Canada |
Co-lead Public Health Agency of Canada & Health Canada |
Harnessing the power of strategic marketing and U=U to strengthen ART Programmes |
Population Services International, Prevention Access Campaign |
Health concerns of transgender people not frequently addressed |
Fundación Huésped |
Highlights from thought leadership symposium on getting to the heart of stigma |
IAS – the International AIDS Society |
HIV and Integration: new WHO Strategies for a sustainable health sector response for 2030 and beyond |
World Health Organization |
HIV and Viral Hepatitis: integrating programmes and financing to accelerate achievement of twin goals to eliminate HIV and viral hepatitis by 2030 |
WHO, PATH, The Hepatitis Fund, CHAI |
HIV cluster sizes in Sub-Saharan Africa |
PANGEA-HIV 2 Consortium |
How inequalities perpetuate pandemics: Why we need a new approach to end AIDS |
UNAIDS |
How lessons learned from the global HIV/AIDS response over the past four decades must inform the global response to COVID-19 and future pandemics |
Global Affairs Canada |
HPTN071(PopART): Where are we, what have we learnt and what is the way forwards for HIV, TB and UTT? |
HPTN 071 (PopART) Study Team |
Implementing needle and syringe programs in Canada: Voices From the Front Line |
Correctional Service Canada |
Improving access to HIV/AIDS medicines with a control tower and data analytics |
i+solutions and KPMG |
In the driver’s seat – Redoubling our investments in the leadership and agency of adolescent and young key populations everywhere |
UNICEF, UNAIDS, UNFPA, UNDP, youth networks |
Innovation in integration: How people-powered services can end AIDS and deliver universal health coverage |
mothers2mothers |
Insights and innovations from Global and U.S. domestic efforts to reach and sustain HIV epidemic control |
U.S. Dept. of State, Dept. of Health and Human Services, and the White House Office of National AIDS Policy |
Launch of the 2022 AJPH Special Issue: Addressing HIV-related intersectional stigma and discrimination to improve outcomes and inform public health efforts |
National Institutes of Health Office of AIDS Research and the National Institute of Mental Health |
Launch of the Global Alliance Initiative to end AIDS in children by 2030: Building partnerships, communities and innovation |
WHO, UNICEF, UNAIDS |
Launching new WHO guidelines for key populations: Focus for impact |
World Health Organization |
Leveraging implementation science to end the HIV epidemic in the United States: Highlighted findings from a JAIDS special issue. |
Implementation Science Coordination Initiative (ISCI) at Northwestern University |
Leveraging the PEPFAR platform: Advancing HIV gains, fighting COVID-19, and strengthening global health security |
PEPFAR |
Mental health and HIV: the emerging and critical dimension in fighting HIV |
United for Global Mental Health, The Lancet, STOPAIDS, Elton John AIDS Foundation, The Global Fund |
Next Generation PrEP: From Science to Community Impact |
The Forum for Collaborative Research |
No time to lose: Action to diagnose and treat the missing 800,000 children |
UNICEF, PEPFAR |
Nudging our way to 95-95-95: a behavioural economics capacity building and implementation research initiative in South Africa |
The Indlela team led by the University of Pennsylvania and the Health Economics & Epidemiology Research Office (HE2RO) |
Our Rights Matter: Advancing Commitments on HIV-AIDS Responses in the UN System |
Aidsfonds – GNP+ |
PANDEMICS & HIV: Failure is not an option |
AIDS Healthcare Foundation |
PrEP-ing for 2030: Why optimization and scale-up of the PrEP service and product mix is critical to addressing unmet PrEP need and supporting effective use towards 2030 HIV prevention goals. |
PATH, AVAC, International AIDS Society |
RADIAN: Supporting the community-led response to HIV in Eastern Europe and Central Asia |
Elton John AIDS Foundation and Gilead Sciences |
Recent infection surveillance as a tool to monitor trends and sharpen prevention strategies to reach and sustain HIV epidemic control? |
Tracking with Recency Assays to Control the Epidemic (TRACE) UCSF, ICAP and CDC |
Reducing inequalities, advancing equity: What it will take to achieve sustained epidemic control of HIV |
PEPFAR |
REPORT LAUNCH: Protectors or Perpetrators? The Impact of Unlawful Policing on HIV, Human Rights and Justice |
Frontline AIDS |
Robert Carr Memorial Lecture and Award Ceremony |
ICASO |
Save lives, decriminalize: Pathways to achieving the 10-10-10s |
UNAIDS |
Self-testing to enhance HIV, Hepatitis C and Covid-19 diagnosis and integrated, differentiated service delivery |
Unitaid and Population Services International |
Sexual and reproductive health and rights, Young People and HIV: The Need for a Comprehensive Response |
IPPF |
Smart Money: Donor commitments to children and adolescents affected by HIV in the COVID era |
The Coalition for Children Affected by AIDS |
South African HIV, TB and STI Progress Beyond COVID-19: Rising Against All Odds |
South African National AIDS Council (SANAC) Trust |
Starting and managing needle and syringe programmes in prisons and other closed settings – country experience |
Clinical Services & Public Health Branch, Correctional Services Canada, Government of Canada and UNODC HIV/AIDS Section |
Stories of Leadership: Making an Impact for Women and Girls in the HIV Response |
UN Women |
Strengthening health systems for holistic HIV prevention, cervical cancer and female genital schistosomiasis prevention and control services |
Frontline AIDS, WHO, UNAIDS, Avert, Merck KGaA (Darmstadt, Germany), Charité – Universitätsmedizin Berlin, PARSGO, ICASO |
Swinging into full gear: Strengthening industry engagement in HIV vaccine research and development |
IAS – the International AIDS Society |
Telehealth innovations for HIV services |
EpiC Project, WHO, and UNAIDS |
The Blantyre Prevention Strategy: A New Way of Doing Business in HIV Prevention |
Georgetown University Center for Innovation in Global Health and the Malawi National AIDS Commission |
The impact of COVID-19 on access to STBBI-related health services: Results from surveys in Canada |
Public Health Agency of Canada |
The Journey to Ending AIDS, Community Cooperation and Empowerment in China |
Chinese Preventive Medicine Association |
The Key Populations Investment Fund: Progress, pitfalls, and future directions for key population programs |
EpiC Project, Johns Hopkins University, and MPact |
The next frontier for HIV treatment optimization: Lessons from the past and visions for the future |
Clinton Health Access Initiative Inc. (CHAI) and Unitaid |
The Road to Zero: successes, learnings, and the work ahead to end advanced HIV disease-related mortality |
Clinton Health Access Initiative, Inc. (CHAI) and Unitaid |
The Robert Carr Fund “Funding what’s possible” Celebrating a decade of supporting regional and global civil society and community led networks in the HIV response |
The Robert Carr Fund for Civil Society Networks |
The science of differentiated service delivery: Where we are and where we’re going |
IAS – the International AIDS Society |
Trans Inclusion in National HIV Policy and Planning: A collaborative discussion between activists, researchers, and policy makers |
Global Action for Trans Equality |
Treatment Optimisation: Lessons from ADVANCE, DolPHIN 2 and NAMSAL trials |
The TRIO team led by Ezintsha |
What has COVID-19 changed in vaccine R&D and what remains to change for an HIV vaccine? |
IAS – the International AIDS Society/Global HIV Vaccine Enterprise |
What the HIV Movement Brings to Pandemic Prevention, Preparedness, and Response |
Frontline AIDS |
What’s new in WHO guidelines: innovations, access and monitoring |
World Health Organization |
Why and how to educate about U=U in clinical, advocacy, and community spaces |
COCQ-SIDA, Prevention Access Campaign, Terrence Higgins Trust |
Will mRNA lead to a long-awaited HIV vaccine? |
IAS – the International AIDS Society/Global HIV Vaccine Enterprise |
Youth resilience: learning from young people’s leadership in tough times |
Global Network for Young People Living with HIV (Y+ Global) |